Healthcare Outcomes Performance Company

HOPCo operates as a permanent holding company and management services organization (MSO), not a fund. It acquires controlling or equity stakes in physician practices with no predetermined exit timeline. Revenue derives from practice operations and shared savings under value-based care contracts, rather than from a carried-interest structure typical of a PE fund.

The firm is physician-led, with practicing surgeons holding key executive roles alongside professional management. Public records do not identify a single named CIO or CEO responsible for all investment decisions. The shareholder base includes partner physicians who hold equity in the practices HOPCo supports, making governance distributed across clinical and administrative leadership.

HOPCo provides a centralized platform for revenue cycle management, payer contract negotiation, implant and supply-chain analytics, and clinical pathway standardization. The firm installs its proprietary technology stack into partner practices and health system orthopedic service lines. The objective is to reduce the cost per episode of care while moving surgical volume into lower-cost ambulatory surgery center settings.

Partnerships originate through direct outreach to large independent orthopedic and spine groups, as well as through exclusive operating agreements with regional health systems that want to outsource musculoskeletal service line management. HOPCo's existing national network of over 100 practices creates referral channels and peer endorsements that feed its pipeline, though no specific sourcing disclosures exist.

HOPCo University serves as the firm's educational arm, training surgeons and practice administrators on value-based care delivery. This suggests a commitment to clinical education, though it is housed within the for-profit entity. No separately registered philanthropic foundation or academic research entity attributable to HOPCo appears in public records.

The firm's economic model is heavily tied to the expansion of episode-based bundled payments and Medicare Advantage risk contracting. If CMS or commercial payers reverse course on value-based care mandates, HOPCo's shared-savings revenue stream would contract. The firm carries this regulatory risk across all its markets, with no publicly disclosed hedging mechanism beyond its scale and payer diversification.

HOPCo has not publicly disclosed any institutional capital raises, precluding definitive statements about external LP participation. The firm's structure as a private, physician-owned MSO suggests it is self-funded through operating cash flow and individual physician equity contributions. No SEC filings indicating a fundraise or a registered fund structure are identifiable from public records.